Stay updated on Sitravatinib Combo in Clear-Cell RCC Clinical Trial
Sign up to get notified when there's something new on the Sitravatinib Combo in Clear-Cell RCC Clinical Trial page.

Latest updates to the Sitravatinib Combo in Clear-Cell RCC Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed, which is a minor metadata update and does not affect study content or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedThe change is a minor version update from v3.4.0 to v3.4.1 with no visible impact on the page content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check34 days agoChange DetectedShow glossary and Hide glossary toggles were added to the page; there are minor label/capitalization changes (Last Update Submitted that Met QC Criteria vs met QC Criteria, No FEAR Act Data vs data) and the Revision tag updated to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check42 days agoChange DetectedThe page now displays a new site revision label: Revision: v3.3.4, replacing Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a Locations section listing Texas as a site; removed the HHS Vulnerability Disclosure and the Texas Locations entry.SummaryDifference0.2%

- Check92 days agoChange DetectedThe publication status text updated to indicate auto-fill from PubMed and the revision version updated to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Sitravatinib Combo in Clear-Cell RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitravatinib Combo in Clear-Cell RCC Clinical Trial page.